NOX 4.55% 10.5¢ noxopharm limited

Novartis Vision trial result, page-19

  1. 546 Posts.
    lightbulb Created with Sketch. 242
    it means exactly that- yes Vision it’s in public domain but it’s unpublished in the sense that at present the trial results have been communicated in abstract form for Congress and via Novartis press release , not fully published in a journal - a non issue as I expect it will be.

    of course they won’t sue, they’ll be preoccupied meeting a worldwide regulatory submission process. It’s simply a poor look for Nox to ride Novartis coat tails in this way, imo. Comes across as a bit desperate.
    Hmmm... Lutetium arm of vision n= 550; Lupin n= 56. Ten fold sample size difference and the Nox crew claiming they’ve added further 4 months survival. Hmmm...
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
10.5¢
Change
-0.005(4.55%)
Mkt cap ! $30.68M
Open High Low Value Volume
10.5¢ 10.5¢ 10.5¢ $6.962K 66.3K

Buyers (Bids)

No. Vol. Price($)
6 226945 10.5¢
 

Sellers (Offers)

Price($) Vol. No.
12.0¢ 38999 2
View Market Depth
Last trade - 14.36pm 11/11/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.